Cargando…
Amyloid Beta (A4) Precursor Protein: A Potential Biomarker for Recurrent Nasopharyngeal Carcinoma
BACKGROUND AND AIM: Nasopharyngeal carcinoma (NPC) is one of the most common cancers in Southern China, Southeast Asia. Radiotherapy is the main treatment for NPC. Still, about 20% of patients with NPC have a recurrence. No effective serum biomarkers are available for recurrent nasopharyngeal carcin...
Autores principales: | Li, Xiao-Yu, Meng, Hui-Ling, Li, Kai-Guo, Yang, Xiao-Hui, Zhu, Xiao-Dong, Li, Ling, Liang, Zhong-Guo, Pan, Xin-Bin, Zeng, Fan-Yan, Qu, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929967/ https://www.ncbi.nlm.nih.gov/pubmed/31908537 http://dx.doi.org/10.2147/CMAR.S218030 |
Ejemplares similares
-
Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy
por: Lin, Huan, et al.
Publicado: (2017) -
Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach
por: Meng, Huiling, et al.
Publicado: (2017) -
Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy
por: Liang, Zhong-Guo, et al.
Publicado: (2016) -
Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2020) -
Sulfuretin exerts diversified functions in the processing of amyloid precursor protein
por: Chen, Jian, et al.
Publicado: (2020)